Free Trial

Roundhill GLP-1 & Weight Loss ETF Rating

Roundhill GLP-1 & Weight Loss ETF logo
$26.26 +0.07 (+0.27%)
As of 09/5/2025 11:59 AM Eastern

Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

OZEM Aggregate Rating

Moderate Buy
2.58

Holdings in OZEM have an aggregate rating of Moderate Buy based on 196 analyst ratings issued in the past year covering 13 companies (68.3% of the portfolio).

OZEM Aggregate Price Target

$26.26
High Prediction$26.26
Average Prediction$26.26
Low Prediction$26.26

Holdings in OZEM have an aggregate price target of $26.26 and a range of $26.26 to $26.26 covering 13 companies (68.3% of the portfolio).

OZEM Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
Moderate Buy
5 Moderate Buy rating(s)
Hold
3 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 13 OZEM Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
19.54%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$55.15
-1.8%
4.1146 of 5 stars
2.13$81.00 46.9%16Trending News
15.88%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$726.35
-2.2%
5 of 5 stars
2.70$950.17 30.8%23Trending News
4.42%
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
$22.08
+11.7%
2.9171 of 5 stars
3.00$75.71 242.9%8Positive News
4.01%
Pfizer Inc. stock logo
PFE
Pfizer
$24.86
+1.3%
4.898 of 5 stars
2.39$28.12 13.1%18Trending News
3.87%
Metsera Inc. stock logo
MTSR
Metsera
$35.87
-1.2%
N/A3.00$59.00 64.5%5News Coverage
Positive News
Analyst Forecast
3.44%
AstraZeneca PLC stock logo
AZN
AstraZeneca
$81.70
-0.1%
2.6983 of 5 stars
2.80$86.00 5.3%5News Coverage
Positive News
3.38%
Amgen Inc. stock logo
AMGN
Amgen
$283.64
+1.3%
4.7381 of 5 stars
2.32$304.43 7.3%22Positive News
Analyst Forecast
2.77%
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
$26.98
+1.7%
4.4067 of 5 stars
3.00$86.92 222.2%14Positive News
2.75%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$7.22
+2.3%
3.8517 of 5 stars
2.60$15.61 116.2%5Trending News
Analyst Forecast
Analyst Revision
2.48%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$573.38
+1.1%
4.7396 of 5 stars
2.82$817.67 42.6%28Positive News
Analyst Upgrade
2.17%
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$31.41
-3.2%
4.5094 of 5 stars
3.20$45.75 45.7%10News Coverage
Positive News
1.92%
Biohaven Ltd. stock logo
BHVN
Biohaven
$15.85
-1.4%
3.665 of 5 stars
3.13$55.71 251.4%16Trending News
Analyst Forecast
1.65%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$115.05
+2.0%
4.9537 of 5 stars
2.88$115.39 0.3%26Positive News

This page (NASDAQ:OZEM) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners